Vice President, Development Sciences (Clinical Pharmacology & Nonclinical)
Lycia Therapeutics· South San Francisco
hybrid vp $295k – $350k / year seen live 1 day ago
Lycia Therapeutics is a biotechnology company using its proprietary lysosomal targeting chimera (LYTAC) platform to discover and develop best-in-class therapeutics that degrade extracellular and membrane-bound proteins. These proteins drive a wide range of difficult-to-treat
Apply on Lycia Therapeutics's site
This link goes straight to the employer's lever page. Posted 144 days ago.We last confirmed it was open 1 day ago.